
PMC:7594251 / 0-417
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T7999 | 358-363 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 235-245 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T2 | 351-357 | Disease | denotes | Cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T77778 | 7-8 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T32708 | 190-191 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T17685 | 206-211 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T97528 | 256-257 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T35994 | 358-363 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 10-14 | Chemical | denotes | Gold | http://purl.obolibrary.org/obo/CHEBI_29287 |
T2 | 131-135 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T3 | 334-338 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
7 | 206-211 | Species | denotes | human | Tax:9606 |
9 | 235-245 | Disease | denotes | infections | MESH:D007239 |
10 | 351-357 | Disease | denotes | Cancer | MESH:D009369 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T77349 | 334-349 | http://purl.obolibrary.org/obo/GO_0042493 | denotes | drug resistance |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 334-349 | Phenotype | denotes | drug resistance | http://purl.obolibrary.org/obo/HP_0020174 |
T2 | 351-357 | Phenotype | denotes | Cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-60 | Sentence | denotes | NMR as a “Gold Standard” Method in Drug Design and Discovery |
T2 | 62-70 | Sentence | denotes | Abstract |
T3 | 71-224 | Sentence | denotes | Studying disease models at the molecular level is vital for drug development in order to improve treatment and prevent a wide range of human pathologies. |
T4 | 225-350 | Sentence | denotes | Microbial infections are still a major challenge because pathogens rapidly and continually evolve developing drug resistance. |